Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2017

01-10-2017 | Original Article

Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction

Authors: A. Ioakeimidou, E. Pagalou, M. Kontogiorgi, E. Antoniadou, K. Kaziani, K. Psaroulis, E. J. Giamarellos-Bourboulis, A. Prekates, N. Antonakos, P. Lassale, C. Gogos, on behalf of the Hellenic Sepsis Study Group

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2017

Login to get access

Abstract

How circulating inflammatory mediators change upon sepsis progression has not been studied. We studied the follow-up changes of circulating vasoactive peptides and cytokines until the improvement or the worsening of a patient and progression into specific organ dysfunctions. In a prospective study, concentrations of tumor necrosis factor-alpha (TNFα), interleukin (IL)-6, IL-8, IL-10, interferon-gamma (IFNγ), endocan and angiopoietin-2 (Ang-2) were measured in serum by an enzyme immunoassay in 175 patients at baseline; this was repeated within 24 h upon progression into new organ dysfunction (n = 141) or improvement (n = 34). Endocan and Ang-2 were the only parameters that were significantly increased among patients who worsened. Any increase of endocan was associated with worsening with odds ratio 16.65 (p < 0.0001). This increase was independently associated with progression into acute respiratory distress syndrome (ARDS) as shown after logistic regression analysis (odds ratio 2.91, p: 0.002). Changes of circulating cytokines do not mediate worsening of the critically ill patients. Instead endocan and Ang2 are increased and this may be interpreted as a key-playing role in the pathogenesis of ARDS and septic shock. Any increase of endocan is a surrogate of worsening of the clinical course.
Literature
1.
go back to reference Dabar G, Harmouche C, Salameh P, Jaber BL, Jamaleddine G, Waked M, Yazbeck P (2015) Community- and healthcare-associated infections in critically ill patients: a multicenter cohort study. Int J Infect Dis 37:80–85CrossRefPubMed Dabar G, Harmouche C, Salameh P, Jaber BL, Jamaleddine G, Waked M, Yazbeck P (2015) Community- and healthcare-associated infections in critically ill patients: a multicenter cohort study. Int J Infect Dis 37:80–85CrossRefPubMed
2.
go back to reference Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801–810CrossRefPubMedPubMedCentral Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801–810CrossRefPubMedPubMedCentral
3.
4.
go back to reference Tsigkos S, Koutsilieris M, Papapetropoulos A (2003) Angiopoietins in angiogenesis and beyond. Expert Opin Investig Drugs 12:933–941CrossRefPubMed Tsigkos S, Koutsilieris M, Papapetropoulos A (2003) Angiopoietins in angiogenesis and beyond. Expert Opin Investig Drugs 12:933–941CrossRefPubMed
5.
go back to reference Bechard D, Gentina T, Delehedde M, Scherpereel A, Lyon M, Aumercier M, Vazeux R, Richet C, Degand P, Jude B, Janin A, Fernig DG, Tonnel AB, Lassalle P (2001) Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem 276:48341–48349CrossRefPubMed Bechard D, Gentina T, Delehedde M, Scherpereel A, Lyon M, Aumercier M, Vazeux R, Richet C, Degand P, Jude B, Janin A, Fernig DG, Tonnel AB, Lassalle P (2001) Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem 276:48341–48349CrossRefPubMed
6.
go back to reference Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:1250–1256CrossRefPubMed Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:1250–1256CrossRefPubMed
7.
go back to reference Calandra T, Cohen J (2005) The international sepsis forum consensus definitions of infections in the intensive care unit. Crit Care Med 33:1639–1648CrossRef Calandra T, Cohen J (2005) The international sepsis forum consensus definitions of infections in the intensive care unit. Crit Care Med 33:1639–1648CrossRef
8.
go back to reference Wada H, Matsumoto T, Yamashita Y (2014) Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care 2:15CrossRefPubMedPubMedCentral Wada H, Matsumoto T, Yamashita Y (2014) Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care 2:15CrossRefPubMedPubMedCentral
9.
go back to reference Pauly D, Hamed S, Behnes M, Lepiorz D, Lang S, Akin I, Borggrefe M, Bertsch T, Hoffmann U (2016) Endothelial cell-specific molecule-1/endocan: diagnostic and prognostic value in patients suffering from severe sepsis and septic shock. J Crit Care 31:68–75CrossRefPubMed Pauly D, Hamed S, Behnes M, Lepiorz D, Lang S, Akin I, Borggrefe M, Bertsch T, Hoffmann U (2016) Endothelial cell-specific molecule-1/endocan: diagnostic and prognostic value in patients suffering from severe sepsis and septic shock. J Crit Care 31:68–75CrossRefPubMed
10.
go back to reference De Freitas CN, Legendre B, Parmentier E, Scherpereel A, Tsicopoulos A, Mathieu D, Lasalle F (2013) Identification of a 14kDa fragment generated by cathepsin G, a novel circulating biomarker in sepsis. J Pharm Biomed Anal 78-79:45–51CrossRef De Freitas CN, Legendre B, Parmentier E, Scherpereel A, Tsicopoulos A, Mathieu D, Lasalle F (2013) Identification of a 14kDa fragment generated by cathepsin G, a novel circulating biomarker in sepsis. J Pharm Biomed Anal 78-79:45–51CrossRef
11.
go back to reference Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, Jourdain M, Pugin J, Tonnel AB, Lassalle P (2006) Endocan, a new endothelial marker in human sepsis. Crit Care Med 34:532–537CrossRefPubMed Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, Jourdain M, Pugin J, Tonnel AB, Lassalle P (2006) Endocan, a new endothelial marker in human sepsis. Crit Care Med 34:532–537CrossRefPubMed
13.
go back to reference Mikkelsen ME, Shah CV, Scherpereel A, Lanken PN, Lassalle P, Bellamy SL, Localio AR, Albelda SM, Meyer NJ, Christie JD (2012) Lower serum endocan levels are associated with the development of acute lung injury after major trauma. J Crit Care 237:522.e11–522.e17CrossRef Mikkelsen ME, Shah CV, Scherpereel A, Lanken PN, Lassalle P, Bellamy SL, Localio AR, Albelda SM, Meyer NJ, Christie JD (2012) Lower serum endocan levels are associated with the development of acute lung injury after major trauma. J Crit Care 237:522.e11–522.e17CrossRef
14.
go back to reference Palud A, Parmentier-Secrucq E, Pastre J, De Freits Caires N, Lassalle P, Mathieu D (2015) Evaluation of endothelial biomarkers as predictors of organ failures in septic shock patients. Cytokine 73:213–218CrossRefPubMed Palud A, Parmentier-Secrucq E, Pastre J, De Freits Caires N, Lassalle P, Mathieu D (2015) Evaluation of endothelial biomarkers as predictors of organ failures in septic shock patients. Cytokine 73:213–218CrossRefPubMed
15.
go back to reference Mihajlovic DM, Lendak DF, Brkic SV, Draskovic BG, Mitic GP, Novakon Mikic AS, Novakov Mikic AS, Cebovic TN (2014) Endocan is a useful biomarker of survival and severity in sepsis. Microvasc Res 93:92–97CrossRefPubMed Mihajlovic DM, Lendak DF, Brkic SV, Draskovic BG, Mitic GP, Novakon Mikic AS, Novakov Mikic AS, Cebovic TN (2014) Endocan is a useful biomarker of survival and severity in sepsis. Microvasc Res 93:92–97CrossRefPubMed
16.
go back to reference Tang L, Zhao Y, Wang D, Deng W, Li C, Li Q, Huang S, Shu C (2014) Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Mediat Inflamm 2014:625180 Tang L, Zhao Y, Wang D, Deng W, Li C, Li Q, Huang S, Shu C (2014) Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Mediat Inflamm 2014:625180
17.
go back to reference Giamarellos-Bourboulis EJ, van de Veerdonk FL, Mouktaroudi M, Raftogiannis M, Antonopoulou A, Joosten LA, Pickkers P, Savva A, Georgitsi M, van der Meer JW, Netea MG (2011) Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia. Crit Care 15:R27CrossRefPubMedPubMedCentral Giamarellos-Bourboulis EJ, van de Veerdonk FL, Mouktaroudi M, Raftogiannis M, Antonopoulou A, Joosten LA, Pickkers P, Savva A, Georgitsi M, van der Meer JW, Netea MG (2011) Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia. Crit Care 15:R27CrossRefPubMedPubMedCentral
18.
go back to reference Leentjens J, Kox M, Koch RM, Preijers F, Joosten LA, van der Hoeven JG, Netea MG, Pickkers P (2012) Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med 186:838–845CrossRefPubMed Leentjens J, Kox M, Koch RM, Preijers F, Joosten LA, van der Hoeven JG, Netea MG, Pickkers P (2012) Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med 186:838–845CrossRefPubMed
Metadata
Title
Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction
Authors
A. Ioakeimidou
E. Pagalou
M. Kontogiorgi
E. Antoniadou
K. Kaziani
K. Psaroulis
E. J. Giamarellos-Bourboulis
A. Prekates
N. Antonakos
P. Lassale
C. Gogos
on behalf of the Hellenic Sepsis Study Group
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-2988-6

Other articles of this Issue 10/2017

European Journal of Clinical Microbiology & Infectious Diseases 10/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.